Monsenso AS (OCSE:MONSO) Growth Rank: 3 (As of Aug. 21, 2026) — 200% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OCSE:MONSO Monsenso AS OCSE:MONSO
25 GF Score
Price kr0.30
GF Value kr0.15
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Monsenso AS Growth Rank?

Monsenso AS OCSE:MONSO +19.05% 25 Growth Rank is 3 as of Aug. 21, 2026, which is 200% above its 10-year median of 1.00. GuruFocus rates OCSE:MONSO with a GF Score™ of 25/100 and a GF Value™ of kr0.15 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Monsenso AS has the Growth Rank of 3.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

OCSE:MONSO vs VEEV, BTSG, HQY: Growth Rank Comparison

For the Health Information Services subindustry, Monsenso AS's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Monsenso AS Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Monsenso AS's Growth Rank distribution charts can be found below:

* The bar in red indicates where Monsenso AS's Growth Rank falls into.


OCSE:MONSO
25GF Score
Monsenso AS OCSE:MONSO
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 3 mean?
Monsenso AS (OCSE:MONSO) has a Growth Rank of 3 as of Aug. 21, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Monsenso AS and its competitors. This is 200% above median its historical median of 1.00. Over the past decade, Monsenso AS's Growth Rank has ranged from 1.00 to 3.00.
Is Monsenso AS's Growth Rank too high?
Monsenso AS's current Growth Rank of 3 is 200% above median its 10-year median of 1.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 3.00. Overall, Monsenso AS has a GF Score™ of 25/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Monsenso AS's Growth Rank compare to VEEV and BTSG?
Monsenso AS's Growth Rank of 3 can be compared against companies in the Healthcare Providers & Services industry. Historically, Monsenso AS's own Growth Rank has ranged from 1.00 to 3.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Monsenso AS and its competitors. Monsenso AS's current Growth Rank is 3, which is 200% above median its own 10-year median of 1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monsenso AS stock overvalued right now?
Based on GuruFocus' analysis, Monsenso AS (OCSE:MONSO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.15, compared to a current price of kr0.30 — trading 100% above its estimated fair value. The current Growth Rank is 3, which is 200% above median its 10-year median of 1.00. Monsenso AS's overall GF Score™ is 25/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Monsenso AS (OCSE:MONSO), the current Growth Rank is 3 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Monsenso AS (OCSE:MONSO) Overvalued in 2026?

Based on GuruFocus' analysis, Monsenso AS stock appears to be overvalued. The current stock price of kr0.30 is trading 100% above its estimated GF Value™ of kr0.15. GuruFocus considers Monsenso AS to be Significantly Overvalued.

Key valuation signals for OCSE:MONSO:

  • Growth Rank: 3 (200% above median its 10-year median of 1.00)
  • GF Value™: kr0.15 vs. price of kr0.30 (100% above fair value)
  • GF Score™: 25/100 with 8 warning signs

No single metric tells the full story. See the OCSE:MONSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Monsenso AS Business Description

Address Rosenorns Alle 31, 2, Frederiksberg, DNK, DK-1970
Monsenso AS is a mobile mental health company. It technology company offering a digital health solution used for decentralized trials, remote patient monitoring, and treatment support. The company's mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data, and the solution helps optimise the treatment and gives a detailed overview of an individual's health through the collection of outcome, adherence, and behavioral data.
25GF Score

Get the complete analysis for OCSE:MONSO

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.30
Price
kr0.15
GF Value